171–180 of 245 posts
Eat healthy. Do sports. Sleep well. Repeat.
Everyone’s path is a little different. What is only a little difficult for some might be downright impossible for others (or feel that way).
Earlier quoted context omitted.
I always wonder-in this case of such an epic company fuck up, does anyone ever get fired? Or is responsibility so diffuse that nobody is ultimately responsible? Pharma companies are really nothing more than holders of time-limited, expensive, exclusive IP. The number one priority should be to maintain those protections as long as possible. How could any patent be allowed to lapse, even if there was limited commercial…
> Or is responsibility so diffuse that nobody is ultimately responsible It doesn't take a very large company for this to happen. I've seen it in a sub 50 person company. There is a task to be done but no one can do it because everyone involved is waiting for someone else to do something. It's like a Mexican standoff.
Boggles my mind.
Earlier quoted context omitted.
Saying pharma companies are just holders of ‘expensive, time-limited IP’ is not only wrong, it’s offensive to those of us who actually do the science. We spend years designing, testing, and validating drugs, not scheming to hike prices. We’re not all Shkrelis out here.
I may be wrong, but aren't most drugs sold by large pharma companies actually developed elsewhere and then acquired?
> Prof. Michael Hoffman from Toronto put me on to the Canadian Patent Database, where you can find that Novo did file a patent there for semaglutide. . .but the last time they paid the annual maintenance fee on it was 2018! > You can even find a letter where their lawyers send a refund request for the 2017 maintenance fee ($250) because Novo apparently wanted some more time to see if they wanted to pay it. > On the s…
I always wonder-in this case of such an epic company fuck up, does anyone ever get fired? Or is responsibility so diffuse that nobody is ultimately responsible? Pharma companies are really nothing more than holders of time-limited, expensive, exclusive IP. The number one priority should be to maintain those protections as long as possible. How could any patent be allowed to lapse, even if there was limited commercial…
(Novo hired _way_ too many people because 'infinite money')
Earlier quoted context omitted.
> got themselves a military base being built on American land now too As a European I'm as critical of the US government as can be and their president has definitely been bought, but there are already several countries that have some training facilities and military personnel in the US. Calling it a foreign military base is really unnecessarily hyperbolic. And given the amount of military bases that the US have on fo…
I suspect he was repeating a soundbite and doesn’t know the actual (entirely reasonable) situation.
For their own security protocols, among other reasons, many partner nations prefer to have a small area set up, think of it like a consulate, where their people stay within their own jurisdiction, rather than a hotel. The UAE is setting up such a place for its pilots.
That is all.
This isn’t a force-projection military base on US soil.
Earlier quoted context omitted.
Some people, including legal experts, claim it could have been intentional: https://www.legal.io/articles/5691258/Novo-Nordisk-Lets-Cana... . I was surprised Science didn't discuss this option. However, reader comments in Science do comment on this possibility. The idea is that letting the patent lapse would avoid getting regulated by the Patented Medicine Prices Review Board. I know several people working at NN, and…
Just FYI, this isn't "by Science", it's by Derek Lowe, this is his blog, which is hosted on Science>Commentary>Blogs. In its description, Lowe says it is "editorially independent".
Does it mean that Sandoz can start production of a generic in Canada and sell it e.g. in Europe?
Earlier quoted context omitted.
Some people, including legal experts, claim it could have been intentional: https://www.legal.io/articles/5691258/Novo-Nordisk-Lets-Cana... . I was surprised Science didn't discuss this option. However, reader comments in Science do comment on this possibility. The idea is that letting the patent lapse would avoid getting regulated by the Patented Medicine Prices Review Board. I know several people working at NN, and…
Just FYI, this isn't "by Science", it's by Derek Lowe, this is his blog, which is hosted on Science>Commentary>Blogs. In its description, Lowe says it is "editorially independent".